Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary soluti...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Zylox-Tonbridge, a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interventional p...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Cente...
The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
Germany-based Merz Aesthetics, the world’s largest dedicated medical aesthetics business, has launched flagship pr...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
